Quantitation of CD62, soluble CD62, and lysosome‐associated membrane proteins 1 and 2 for evaluation of the quality of stored platelet concentrates

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Transfusion

• Publication date

  1995-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1537-2995.1995.35495216076.xPMID 7535481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias.

  1993cited by this paper
• Detection of platelet‐derived microparticles in patients with diabetes

  1993cited by this paper
• Comparison of platelet membrane markers for the detection of platelet activation in vitro and during platelet storage and cardiopulmonary bypass surgery.

  1993cited by this paper
• E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels.

  1993cited by this paper
• The effects of calpeptin (a calpain specific inhibitor) on agonist induced microparticle formation from the platelet plasma membrane.

  1993cited by this paper
• Biochemical and immunohistochemical characteristics of CD62 and CD63 monoclonal antibodies

  1992cited by this paper
• Alterations of the levels of glycoproteins Ib-IX and IIb-IIIa in platelets stored at 22 degrees C.

  1992cited by this paper
• Identification of lysosome-associated membrane protein-2 as an activation-dependent platelet surface glycoprotein.

  1992cited by this paper
• Characterization of GMP-140 (P-selectin) as a circulating plasma protein

  1992cited by this paper
• Clinical significance of platelet microparticles in autoimmune thrombocytopenias.

  1992cited by this paper
• The use of inhibitors of platelet activation or protease activity in platelet concentrates stored for transfusion.

  1992cited by this paper
• Changes in platelet membrane glycoproteins during blood bank storage.

  1992cited by this paper
• A monoclonal antibody-based enzyme immunoassay for human GMP-140/P-selectin.

  1992cited by this paper
• Reactions to platelet transfusion: the effect of the storage time of the concentrate

  1992cited by this paper
• Alterations of the levels of glycoproteins Ib-IX and IIb-IIIa in platelets stored at 22°C

  1992cited by this paper
• Changes in platelet membrane glycoproteins during blood bank storage.

  1992cited by this paper
• Vesiculation of platelets during in vitro aging.

  1991cited by this paper
• Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles.

  1991cited by this paper
• Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.

  1991cited by this paper
• Microparticle generation during in vitro platelet activation by anti-CD9 murine monoclonal antibodies.

  1991cited by this paper
• Platelet-derived microparticles express high affinity receptors for factor VIII.

  1991cited by this paper
• Direct detection of activated platelets and platelet-derived microparticles in humans.

  1990cited by this paper
• A new competitive binding enzyme-linked immunosorbent assay for glycocalicin in plasma and platelet concentrate supernatants.

  1990cited by this paper
• Measurement of platelet activation by fluorescence-activated flow cytometry.

  1990cited by this paper
• Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity.

  1989cited by this paper
• Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycan.

  1988cited by this paper
• Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.

  1985cited by this paper
• Isolation of human platelet membrane microparticles from plasma and serum.

  1982cited by this paper

• Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat

  2024cites this paper
• Platelet in vitro assays: their correspondence with their in vivo hemostatic potential

  2019cites this paper
• Platelet Transfusion Medicine

  2019cites this paper
• Functional recovery of stored platelets after transfusion

  2016cites this paper
• A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders

  2015cites this paper
• Platelet‐derived extracellular vesicles in plateletpheresis concentrates as a quality control approach

  2015cites this paper
• von Willebrand factor, clotting factors, and clotting inhibitors in apheresis platelet concentrates

  2014cites this paper
• Immunomodulatory mediators in platelet transfusion reactions.

  2011cites this paper
• The platelet storage lesion.

  2010cites this paper
• Fizjologiczna i patogenna aktywność mikrocząstek błon komórkowych

  2010cites this paper
• Pre-analytical and methodological challenges in red blood cell microparticle proteomics.

  2010cites this paper
• The platelet storage lesion.

  2009cites this paper
• Toll‐like receptor 4 ligand can differentially modulate the release of cytokines by human platelets

  2008cites this paper
• Platelet microparticles contain active caspase 3

  2008cites this paper
• Dielectrophoretic separation of platelets from diluted whole blood in microfluidic channels

  2008cites this paper
• In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma‐irradiated single‐donor platelet concentrates during long‐term storage

  2007influential citation
• Vesna Subota.qxp

  2007cites this paper
• Evaluation of Platelet Activation Parameters as Quality Markers for the Stored Platelets

  2007cites this paper
• Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers.

  2006cites this paper
• Platelet activation during plasma‐reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators

  2004cites this paper
• Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters

  2004cites this paper
• Potential involvement of Platelet-Derived microparticles during percutaneous transluminal coronary angioplasty

  2004cites this paper
• Platelet microparticles as carriers of soluble Alzheimer's amyloid beta (sAbeta).

  2002cites this paper
• Platelet Microparticles as Carriers of Soluble Alzheimer's Amyloid β (sAβ)

  2002cites this paper
• Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates

  2002cites this paper
• Autologous transfusion recovery of WBC‐reduced high‐concentration platelet concentrates

  2002cites this paper
• Platelet storage lesion of WBC‐reduced, pooled, buffy coat‐derived platelet concentrates prepared in three in‐process filter/storage bag combinations

  2001cites this paper
• Influence of gamma irradiation and storage on apheresis platelets.

  2001cites this paper
• Effects of DMSO on platelet functions and P-selectin expression during storage.

  2001cites this paper
• Paired comparison of apheresis platelet function after storage in two containers

  2001cites this paper
• Flow Cytometric Analysis of Platelets

  2000cites this paper
• Quantification of platelet activation status by analyzing P-selectin expression.

  2000cites this paper
• Evaluation of platelet function by flow cytometry.

  2000cites this paper
• Changes in Glycoprotein Expression after Platelet Activation: Differences between In Vitro and In Vivo Studies

  2000cites this paper
• Microvesicles in platelet concentrates for transfusion.

  2000cites this paper
• Optimising quality of platelet transfusions

  2000cites this paper
• Platelet membrane early activation markers during prolonged storage.

  1999cites this paper
• Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems

  1999cites this paper
• Safety issues of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, fibrinolysis, and neutrophils and on the formation of neutrophil‐platelet aggregates

  1999cites this paper
• Platelet surface P-selectin measurements in platelet preparations: an international collaborative study. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT).

  1999cites this paper
• Flow cytometric analysis of platelet function in stored platelet concentrates.

  1999cites this paper
• Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans

  1999cites this paper
• Étude de la qualité des concentrés plaquettaires d'aphérèse (CPA) dans le cadre de la validation d'un nouveau processus de séparation COBE spectra turbo

  1999influential citation
• Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage

  1999cites this paper
• Platelets Stored in a New-Generation ContainerDifferences between Plasma and Platelet Additive Solution II

  1998cites this paper
• Vesiculation and Changes in Fluidity and Lipid Composition of Platelet Membranes after Storage of Sheep Platelets in Plasma or Seto Solution

  1998cites this paper
• Platelet activation and turnover in the primary antiphospholipid syndrome

  1998cites this paper
• Platelet activation and its detection during the preparation of platelets for transfusion.

  1998cites this paper
• Platelet activation markers and the primary antiphospholipid syndrome (PAPS)

  1998cites this paper
• Platelets Stored in a New‐Generation Container

  1998cites this paper
• P-selectin (CD62p) and Soluble CD62p (sCD62p) in Platelet Concentrates Stored for Transfusion

  1998cites this paper
• Differential induction of P‐selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P‐selectin

  1998cites this paper
• Loss of high‐affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin

  1997cites this paper
• Improvement of platelet storage conditions by using new polyolefin containers

  1997cites this paper
• BIOLOGICAL FUNCTIONS OF LYSOSOMAL MEMBRANE-ASSOCIATED GLYCOPROTEINS

  1997cites this paper
• Impact of buffy coat storage on the generation of inflammatory cytokines and platelet activation

  1997cites this paper
• Soluble P-selectin as Parameter for Platelet Activation during Storage

  1996cites this paper
• Flow cytometry: a clinical test of platelet function.

  1996cites this paper
• The storage lesion of platelets: ultrastructural and functional aspects

  1996cites this paper